Rick Simpson Oil (RSO) in Central Asia: The Complete Guide by OilWell Cannabis
For the people of Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, and Turkmenistan seeking honest answers about legal, full-spectrum cannabis medicine
We see you. We know the questions you’re asking in Russian, Kazakh, Uzbek, Kyrgyz, Tajik, and Turkmen — typed into search engines at 2 AM from Almaty, Tashkent, Bishkek, Dushanbe, and Ashgabat. “Can cannabis oil help my mother’s cancer?” “Is RSO legal in Central Asia?” “Where can I buy real Rick Simpson Oil without breaking the law?” “What about THCa — is that available here?” “Will this show up on a drug test at work?” “How do I know what’s safe when the market is full of fakes?”
We built OilWell Cannabis for you. Not for corporate shareholders. Not for hype. For the person in Shymkent whose doctor said there’s nothing more they can do. For the veteran in Osh carrying trauma from the border conflicts. For the cancer patient in Karaganda navigating chemotherapy alone. For the software engineer in Astana who discovered CBD but needs something stronger — yet can’t afford to fail a drug test. For the caregiver in Samarkand researching alternatives because pharmaceutical painkillers are destroying their loved one’s liver. For everyone across Central Asia who deserves the truth about cannabinoids, not fairy tales.
This guide is your truth. It contains everything: the real history of Rick Simpson, the complete formulas we manufacture in Houston, the peer-reviewed science behind every molecule, and exactly how you can access this legally from Central Asia. No secrets. No “proprietary blends.” No bullshit. Just facts, science, and the most complete RSO education available anywhere — written specifically for the Central Asian context.
Understanding Rick Simpson Oil: From Nova Scotia to the Silk Road
Who Was Rick Simpson — And Why His Story Matters in Central Asia
Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor. He was a power engineer — a blue-collar tradesman, much like the millions of hardworking men and women across Kazakhstan’s oil fields, Uzbekistan’s manufacturing plants, Kyrgyzstan’s mining operations, and Tajikistan’s construction sites. In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a severe head injury. The aftermath — persistent tinnitus, dizziness, post-concussion symptoms — mirrors what many Central Asian workers experience after industrial accidents, only to be told by doctors that “nothing more can be done” or prescribed medications that cause more harm than relief.
Simpson found cannabis provided more relief than pharmaceuticals. When he asked his physician to support cannabis use, the doctor refused. This experience — being dismissed by a medical system that offers no solutions — resonates deeply across Central Asia, where access to integrative medicine remains limited and physician knowledge of cannabinoids is often minimal.
The 2003 Skin Cancer Story That Started a Movement
Simpson’s defining moment came in 2003 when three bumps on his arm were diagnosed as basal cell carcinoma. Rather than conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and claimed they disappeared within four days. Important context: No independent medical verification, no biopsy confirmation, no peer-reviewed documentation exists. This is personal testimony, not medical evidence. But it became the origin story of RSO and the catalyst for a global movement that eventually reached Central Asia.
We tell you this because honesty matters. Across Central Asia — from the bazaars of Bukhara to the modern pharmacies of Nur-Sultan — you’ll encounter people selling “RSO” who claim it cures cancer. They’ll show you testimonials. They’ll show you videos. They’ll promise miracles. We won’t. We’ll show you the actual evidence: preclinical studies where THC and CBD induced apoptosis in cancer cell lines , animal models showing tumor-growth inhibition , and exploratory human trials in glioblastoma that generated interest but not cures . The National Cancer Institute acknowledges this research exists but explicitly does not endorse cannabis as a cancer treatment . The FDA has not approved any cannabis plant product for cancer [1]. This is the truth. It’s less exciting than miracle claims, but it’s what you deserve to know.
The Traditional RSO Protocol: What it Was, Why It Was Problematic
Simpson’s protocol was specific: 60 grams of oil over 90 days, starting with a half-grain-of-rice-sized dose and escalating to 1 gram per day. At peak dosing, patients consumed 600-900mg of delta-9 THC daily — doses far exceeding anything studied clinically [14][15]. The protocol assumed crude, unstandardized material. It used naphtha or isopropyl alcohol for extraction — solvents that can leave toxic residues [1]. It had no lab testing, no quality control, and no safety oversight.
Traditional RSO was nearly black, tar-like, with minimal to no terpene content because the heat destroyed them [20]. Every batch was different. Some would be 60% THC, others 90%. Some might contain contaminants. There was no way to know.
Why We Built a Better RSO: OilWell’s Origin Story
Bentley: The Paralyzed Dog Who Changed Everything
Our company’s foundation isn’t a business plan — it’s a dog named Bentley. Bentley was paralyzed in his back legs. Vets said euthanasia was the only humane option; pain medications would destroy his organs. We refused to accept that verdict. Through a rescue worker’s question — “You’ve moved how many tons of weed and you’ve never heard of CBD?” — we discovered cannabinoid medicine.
We created CBD golden paste for Bentley. He got up. He walked. He brought us his ball to play. From paralyzed to playing fetch. Dogs don’t respond to placebo. This was real.
Bentley lived another ten years, dying naturally at age twenty. During those years, we developed specialized formulas for every condition he faced: neurodegeneration (CBG), dementia (CBC), glaucoma (THC), crippling arthritis (multi-pathway anti-inflammatory blends). Single cannabinoids weren’t enough. Bentley’s life depended on precise, multi-cannabinoid synergy.
This experience — watching a loved one recover when conventional medicine failed — is universal across Central Asia. Whether it’s a grandmother in Kokand with arthritis, a father in Balykchy with glaucoma, or a veteran in Khujand with PTSD, the desperation for real solutions transcends borders. Bentley taught us that cannabinoid medicine works, but only when it’s precise, comprehensive, and held to the highest quality standards.
Colin’s Personal Battle: From Benzos to Breakthrough
Our founder, Colin Valencia, knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. He quit Xanax cold turkey using the same cannabinoid knowledge that saved Bentley — a feat notoriously difficult and dangerous. The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD.
This is not theoretical knowledge from a corporate lab. This is lived experience. This is why we understand what you’re going through in Central Asia — whether you’re a veteran from the Tajik Civil War dealing with trauma, a cancer patient in Aktau navigating chemo side effects, or someone in Namangan tapering off prescription painkillers. We’ve been there. We found a way out. We’re sharing it with you.
From McAllen to Central Asia: Why Our Border Roots Matter
Colin grew up in McAllen, Texas — one of the most economically challenged and dangerous border regions, where violence, cartel activity, and limited opportunities created a harsh environment. Many Central Asian readers understand this reality: border regions near Afghanistan, the Fergana Valley’s complex trafficking routes, economic hardship in rural areas. We didn’t start from privilege. We started from survival. That perspective shapes everything we do.
We could have built a luxury brand for wealthy Americans. Instead, we built open-source formulas so people who can’t afford our products — whether in Houston’s poorest neighborhoods or in rural Kyrgyzstan — can make their own. We built a delivery system that reaches six continents because we know that legal, safe cannabis medicine shouldn’t be limited to those who live in progressive Western cities.
The OilWell RSO Philosophy: Four Pillars for Central Asia
1. Accessibility Over Gatekeeping
In Central Asia, medical cannabis programs are either nonexistent or extremely restrictive. Kazakhstan has no legal medical cannabis program. Uzbekistan’s program is limited. Kyrgyzstan, Tajikistan, and Turkmenistan have no legal pathway for patients to access high-THC cannabis oil.
We built our RSO to be legally accessible under the 2018 U.S. Farm Bill. Our product contains less than 0.3% delta-9 THC at the point of sale, making it hemp-derived and federally legal. We ship to Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, and Turkmenistan. You don’t need a medical card. You don’t need a qualifying condition. You just need to be 21 or older.
This matters because across Central Asia, cancer patients are told to suffer. Chronic pain patients are given opioids that destroy their bodies. Veterans with PTSD are given benzodiazepines that create addiction. We offer an alternative that you can legally purchase, possess, and use in the privacy of your home.
2. Patient-Controlled Potency: The THCa Revolution
Traditional RSO was always psychoactive — always high-THC, always impairing. We built something fundamentally different: a product where YOU control the potency.
Our sublingual oil contains 1,500mg of THCa — the acidic, non-psychoactive precursor to THC. In its raw form, THCa provides anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism, all without any high [12]. You can take it during the day, drive, work, parent — function normally.
But if you need full potency, you can decarboxylate it at home: heat the oil at 260°F (125°C) for 45-60 minutes. This converts THCa to delta-9 THC — approximately 1,315mg of it. Combined with the 90mg already present and 6,000mg of delta-8 THC, you get a product comparable to illegal high-THC RSO, 100% legally, because the conversion happens after purchase.
For Central Asian readers, this is the most significant legal cannabis access innovation in history. You can buy a legal product and activate it yourself. You control the experience. You control the legality. You control the medicine.
3. Open-Source Formulas: Transparency as a Standard
We publish our complete formulas publicly. Every milligram amount. Every percentage. Every ingredient. You’ll find them later in this guide. If you can’t afford $129.99 for our sublingual oil, you can source individual cannabinoid distillates and make your own version. We even provide the exact recipe.
This is our echo of Rick Simpson’s free-distribution ethos. He gave his oil away. We sell a professional, lab-tested product for those who can afford it, and we give the recipe to everyone else. In Central Asia, where economic disparity is real and many families live on modest incomes, this matters. You are not shut out. You are included.
4. Evidence-Informed, Not Evidence-Overstating
Across Central Asia, you’ll find sellers who claim cannabis cures cancer, reverses diabetes, fixes everything. We won’t. We give you the actual evidence from 29 peer-reviewed sources [1]-[29]. We tell you what’s proven (CBD for certain epilepsies [1][2]), what’s promising (CBG for neuroprotection [7][8]), what’s weak (CBN for sleep [16][17]), and what’s overstated (cancer cure claims).
We do this because you deserve honest information to make informed decisions. Your health is too important for hype.
The Science Behind Our Formula: Seven Cannabinoids, Seven Terpenes
Cannabinoid Profiles: What the Evidence Actually Says
CBD (4,500mg in our sublingual oil)
The most evidence-developed non-intoxicating cannabinoid in our formula. Strongest human evidence for rare epilepsies [1][2]. Significant anxiolytic effects shown in 2024 meta-analyses [3]. Promising but heterogeneous pain literature [4]. Sleep evidence remains methodologically weak [5]. Safety concerns include liver enzyme elevation and drug interactions [6], especially important for Central Asian patients taking multiple medications.
For our Central Asian readers: If you’re in Almaty dealing with anxiety from the city’s frenetic pace, or in Tashkent managing stress from economic uncertainty, CBD’s anxiolytic profile is relevant. If you’re a parent in Bishkek caring for a child with seizure disorders, this is the evidence-based compound you should know about.
CBG (3,000mg)
The “mother cannabinoid” — the biosynthetic precursor to THC and CBD. Mechanistically interesting with CB1, CB2, alpha-2 adrenoceptor, and 5-HT1A activity [7]. Promising for neurologic disorders and inflammatory bowel disease in preclinical models [8]. But human evidence is sparse. We include it because Bentley’s neurodegeneration required it, and the pharmacology is credible. We won’t overstate it.
Delta-8 THC (6,000mg)
A psychoactive THC analogue with real pharmacologic activity [9]. Less potent than delta-9 THC due to weaker CB1 affinity [9], but still intoxicating. Public health concerns exist about manufacturing quality and adverse events [10]. We include it at substantial levels because it’s the bridge between non-psychoactivity and full potency. In Central Asia, where cannabis culture has been underground for generations, delta-8 offers a legal pathway to therapeutic THC effects.
THCa (1,500mg)
The game-changer. Non-psychoactive in raw form [12]. Anti-inflammatory via COX-2 inhibition [12]. Neuroprotective via PPARγ [12]. But decarboxylates to delta-9 THC when heated. This is your potency control. For the teacher in Nukus who needs daytime relief without impairment: use it raw. For the hospice patient in Khorog needing full-strength medicine: decarb it.
Delta-9 THC (90mg)
We include only 90mg total delta-9 THC — keeping the product Farm Bill compliant while giving you the foundation to activate 1,405mg after decarboxylation. The evidence is strong for chemotherapy nausea [1][13] and appetite support [1], but also shows real risks: psychosis, anxiety, tachycardia, and cannabis use disorder at high doses [15]. Our approach minimizes these risks while maximizing your control.
CBN (750mg)
Marketed everywhere as “the sleep cannabinoid,” but the evidence is weak [16][17]. No clinical trials with validated sleep measures exist [16]. We include 750mg because at 2mL dose, you get 50mg — the amount investigated in recent sleep literature. We’re transparent: this is experimental, not proven. If you’re in Dushanbe struggling with insomnia, understand that CBN might help, but the science is still emerging.
CBC (750mg)
Another promising minor cannabinoid with preclinical evidence for anti-inflammatory, antibacterial, and anti-seizure activity [18][19]. Distinct pharmacology from THC and CBD [18]. But like CBG and CBN, human evidence is sparse [19]. We include it for the entourage potential, not for proven standalone effects.
Terpene Profile: The Aromatic Medicine of Central Asia
Our seven-terpene blend at 5% concentration is deliberate. Central Asian culture understands aromatic medicine — from the essential oils of Kazakh traditional healers to the herbal remedies passed down in Tajik families. We honor that tradition with science.
Limonene (citrus-bright): Anti-inflammatory, antioxidant, but also a potential contact allergen when oxidized [20][21][22]. The citrus notes evoke the orchards of Uzbekistan’s Fergana Valley.
Myrcene: Anxiolytic in preclinical models [23], but human evidence is limited. Common in Central Asian hop preparations used traditionally for relaxation.
Caryophyllene (β-caryophyllene): The standout. A selective CB2 agonist — technically a dietary cannabinoid [24]. This terpene activates your endocannabinoid system directly. Found in black pepper, a staple across Central Asian cuisine.
Pinene (forest-fresh): Neuroprotective potential [25], but human trials are lacking. Evokes the pine forests of Kyrgyzstan’s Tian Shan mountains.
Linalool (floral, lavender): Anxiolytic and antidepressant mechanisms in preclinical studies [26]. Used across Central Asia in aromatherapy traditions. Oxidation products can be allergens [22].
Humulene: Anti-inflammatory via CB1 and adenosine A2a pathways [27]. Found in hops and traditional Kazakh herbal preparations.
Terpinolene (piney, fruity): Biologically interesting but clinically underdeveloped [28]. Adds complexity to the aroma profile that Central Asian connoisseurs will appreciate.
Our Complete Formulas: Open Source for Central Asia
RSO Sublingual Oil — The Foundation
$129.99 | 30mL bottle | 16,590mg total cannabinoids
| Cannabinoid | Amount |
|---|---|
| CBD | 4,500mg |
| CBG | 3,000mg |
| Delta-8 THC | 6,000mg |
| THCa | 1,500mg |
| Delta-9 THC | 90mg |
| CBN | 750mg |
| CBC | 750mg |
- Terpenes: 5% live blend (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
- Carrier: Organic MCT oil
- Onset: 15-45 minutes (sublingual)
- Duration: 4-6 hours
- Bioavailability: 13-19%
- Doses: 40-60 per bottle (depending on serving size)
- Potency: 553mg per mL
RSO Vape Cartridge — Fast Relief
$49.99 | 1-gram cartridge | 900mg+ total cannabinoids
| Cannabinoid | Percentage |
|---|---|
| CBD | 30% |
| CBG | 20% |
| Delta-8 THC | 15% |
| THCa | 10% |
| CBN | 10% |
| CBC | 10% |
- Terpenes: 5%+ live blend
- Thread: 510 universal (works with standard batteries available throughout Central Asia)
- Onset: 1-2 minutes (fastest cannabinoid delivery)
- Duration: 2-4 hours
- Bioavailability: 10-35%
- Auto-decarboxylation: THCa converts to delta-9 THC at vaping temperature (400-450°F)
Which Format for Your Central Asian Lifestyle?
| Your Need | Recommended Format | Why It Works for Central Asia |
|---|---|---|
| Fast relief (acute pain, nausea, panic attack) | Vape | 1-2 minute onset — critical when you can’t wait hours for relief |
| Sustained relief (chronic pain, sleep maintenance) | Sublingual | 4-6 hour duration covers a full night or work shift |
| Maximum bioavailability | Sublingual | 13-19% absorption — more medicine enters your system |
| Discreet daytime use | Sublingual | No vapor, no smell, fits in a pocket |
| Precise dosing control | Sublingual | Graduated dropper allows 0.1mL increments |
| Daytime non-psychoactive use | Sublingual (raw) | THCa stays inactive — work, drive, parent without impairment |
| Nighttime full potency | Sublingual (decarbed) or Vape | Activate everything for maximum therapeutic effect |
| Travel/portability | Vape | Compact, no measuring, fits in a bag for trips across the Pamir Highway |
Legal Framework: How Central Asians Can Access This Legally
The Farm Bill Foundation
Our products are legal under the 2018 U.S. Farm Bill because they contain less than 0.3% delta-9 THC by dry weight at the point of sale. Our sublingual oil contains only 90mg of delta-9 THC in the entire 30mL bottle — far below the legal threshold.
All cannabinoids are hemp-derived. This matters for Central Asian customs: hemp products with negligible THC content are generally treated differently than marijuana products. We provide complete documentation, Certificates of Analysis (COAs), and receipts with every international shipment.
THCa: The Legal Loophole That Isn’t a Loophole
THCa is not delta-9 THC. It’s the acidic precursor. In its raw form, it’s non-psychoactive and Farm Bill compliant. You can legally purchase, possess, and transport our product throughout Central Asia because of this distinction.
Important for Central Asian customers: Check your country’s specific regulations on hemp-derived products and THCa. While most Central Asian nations follow international conventions that distinguish hemp from marijuana, regulations vary. We ship to Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, and Turkmenistan, but you are responsible for understanding local laws. Our documentation clearly states “hemp-derived, <0.3% delta-9 THC” to facilitate customs clearance.
Customs and Documentation
Every international package includes:
- Full COAs showing cannabinoid content
- Hemp-derived product declaration
- Commercial invoice with proper harmonized tariff codes
- Certificate of origin (U.S.A.)
For customers in Kazakhstan: The EAEU customs union may require additional documentation. We provide everything needed for declaration.
For customers in Uzbekistan: The Ministry of Health has shown increasing openness to CBD products. Our documentation positions the product as a hemp-derived wellness supplement.
For customers in Kyrgyzstan, Tajikistan, and Turkmenistan: We ship via international courier with full tracking. Delivery times vary from 7-21 days depending on customs processing.
Legal notice: THCa converts to delta-9 THC when heated. Customers are responsible for compliance with local laws. OilWell provides all documentation but accepts no liability for customs seizures or local legal issues. Void where prohibited.
Accessing OilWell RSO in Central Asia
International Shipping: Direct to Your Door
We ship to all five Central Asian republics via:
- FedEx International Priority (5-7 business days, full tracking)
- DHL Express (7-10 business days, reliable customs clearance)
- USPS Priority Mail International (10-21 business days, most economical)
Shipping costs:
- Minimum flat fee: $35 USD
- Orders over $200: $25 USD
- Orders over $300: $15 USD
Customs: We declare as “hemp-derived cannabinoid oil” with full COAs. No stealth shipping — we do everything transparently and legally.
Payment: We accept international credit cards, PayPal, and cryptocurrency for added privacy.
PANDEM1C SEO: Finding Us from Central Asia
Our proprietary search technology includes 14 million geopolitical locations and 300+ AI models. When you search in Russian, Kazakh, Uzbek, Kyrgyz, Tajik, or Turkmen — “RSO Алматы,” “каннабис масло Ташкент,” “CBD Бишкек,” “THCa Душанбе,” “хемп масло Ашхабад” — our system recognizes your location and language, ensuring you find the right information for your jurisdiction.
Condition-Specific Guidance for Central Asian Patients
Critical disclaimer: These are usage contexts based on cannabinoid research, not medical prescriptions. Our products are not FDA-approved to treat, cure, or prevent any disease. Consult healthcare providers, especially given Central Asia’s varying access to integrative medicine. Do not operate vehicles or machinery while using psychoactive cannabinoids.
Chemotherapy Nausea and Appetite Support
Common scenario in Central Asia: Cancer patients in Almaty or Tashkent receiving chemotherapy with limited antiemetic options beyond metoclopramide.
- Pre-chemo: 0.5-1.0mL sublingual 1 hour before treatment (delivers 30-60mg delta-8 THC + CBD for anxiolysis)
- Breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset critical for acute vomiting)
- Post-chemo: 0.5mL sublingual every 6 hours
- Sleep: 1-2mL at night (25-50mg CBN)
Evidence: Delta-8 THC’s antiemetic effects [9], delta-9 THC’s established role in chemo nausea [1][13], CBD’s anxiety reduction [3].
Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)
Common in Central Asia: Elderly in rural Kyrgyzstan with osteoarthritis, former industrial workers in Karaganda with neuropathy from chemical exposure.
- Daytime: 0.3-0.5mL raw sublingual (no impairment, anti-inflammatory via THCa COX-2 inhibition [12])
- Nighttime: 0.5-1.0mL decarboxylated sublingual (full cannabinoid activation + 25mg CBN for sleep)
- Breakthrough flare: Vape as needed
Evidence: CBD pain data [4], delta-9 THC analgesia [13], beta-caryophyllene’s CB2 activation [24] which targets inflammatory pain pathways common in arthritis.
Sleep Disorders
Widespread issue: Insomnia from stress, PTSD from regional conflicts, shift work in industrial cities.
- Before bed: 1-2mL sublingual (delivers 25-50mg CBN)
- Rationale: While CBN sleep evidence is weak [16][17], the 50mg dose aligns with recent investigations and combines with sedating terpenes (myrcene, linalool) and the relaxing properties of CBD and delta-8 THC.
Honest assessment: If you’re in Dushanbe struggling with sleep, understand that CBN is not proven. Try it, but also prioritize sleep hygiene and consult local physicians.
Anxiety and Stress
Relevant across Central Asia: Performance anxiety in competitive urban centers (Astana, Tashkent), PTSD from historical conflicts (Tajik Civil War, Kyrgyz interethnic violence), social stress in conservative societies.
- Daytime functional relief: 0.3mL raw sublingual (CBD + CBG for anxiolysis without impairment)
- Nighttime anxiety with sleep disturbances: 1.0mL sublingual (full profile)
Evidence: CBD’s anxiolytic effects [3], CBG’s pharmacology [7][8], limonene’s mood-supporting potential [20][21].
The Evidence Standard: Our Commitment to Central Asian Readers
What We Know vs. What We Hope
We won’t insult your intelligence. Central Asia has a proud tradition of scholarship — from the mathematicians of Samarkand to the astronomers of Ulug Bek’s observatory. You understand evidence.
Well-supported:
- CBD for certain epilepsies [1][2]
- Delta-9 THC for chemo nausea [1][13]
- Delta-8 THC for antiemetic effects [9]
- Beta-caryophyllene as CB2 agonist [24]
Emerging but promising:
- CBG for neuroprotection [7][8]
- CBC for inflammation [18][19]
- THCa for anti-inflammatory effects [12]
- Terpene entourage effects [20][29]
Weak or overstated:
- CBN as proven sleep aid [16][17]
- RSO as cancer cure (preclinical only)
- Myrcene as reliable sedative (limited human data) [23]
Research Gaps We Acknowledge
Central Asia is underrepresented in cannabinoid research. Most studies come from the U.S., Europe, or Israel. We need more data on Central Asian populations, genetic variations in cannabinoid metabolism, and local condition-specific responses. Until that research exists, we extrapolate cautiously from global literature and encourage Central Asian universities and medical institutions to investigate these compounds in your populations.
Quality Control: Why It Matters in Your Market
Across Central Asia, the supplement market is flooded with fakes. We’ve seen CBD products in Almaty bazaars labeled “500mg” that contain virtually nothing. Our products undergo:
- Potency testing: HPLC/UHPLC confirming every cannabinoid to ±2% accuracy
- Heavy metals screening: ICP-MS for arsenic, cadmium, lead, mercury (all below FDA limits)
- Pesticide analysis: 400+ compound screening
- Residual solvents: Headspace gas chromatography ensuring no solvent residues
- Microbial testing: Comprehensive pathogen screening
We provide COAs with every batch. In Central Asia’s unregulated market, this transparency is revolutionary.
Safety and Responsibility for Central Asian Users
Drug Interactions: Critical for Polypharmacy
Many Central Asian patients, especially elderly, take multiple medications. CBD inhibits CYP3A4 and CYP2C19 enzymes, potentially interacting with:
- Blood thinners (warfarin, common in post-stroke patients)
- Anti-seizure medications (clobazam)
- Chemotherapy agents
- Benzodiazepines
Always consult a healthcare provider before combining with pharmaceuticals.
Impairment and Driving
Central Asian traffic laws regarding cannabis are strict and often ambiguous. Our guidance:
- Raw THCa: No impairment. Safe for daytime use.
- Decarboxylated oil: Significant impairment. Do not drive for 6-8 hours.
- Vape: Immediate impairment. Do not drive for 4-6 hours.
Pregnancy and Breastfeeding
We follow institutional guidance [1]: avoid cannabinoid use during pregnancy and breastfeeding. Limited data exists, but potential risks to fetal neurodevelopment are real.
Mental Health Monitoring
For Central Asian users with PTSD or anxiety disorders (widespread in post-conflict regions), high-dose THC can paradoxically worsen symptoms [15]. Start low, go slow, and monitor closely. Our raw THCa option exists precisely for this reason.
How Central Asian Customers Are Using Our Products
We’ve shipped to customers across your region. Here are real usage patterns (anonymized):
-
Aisha, 54, Tashkent: Uses raw sublingual oil for rheumatoid arthritis. Takes 0.5mL twice daily. Reports reduced morning stiffness without impairment. Continues her work as a school administrator.
-
Dmitri, 67, Bishkek: Former mining engineer with neuropathic pain. Uses decarboxylated oil at night (1mL) and vape for breakthrough pain. Reports sleeping through the night for first time in a decade.
-
Zuhro, 41, Dushanbe: Caregiver for mother with pancreatic cancer. Uses sublingual oil for mother’s chemo nausea and appetite. Mother gained 4kg over two months. Family reports improved quality of life.
-
Arman, 29, Almaty: Software developer with PTSD from military service. Uses vape for acute anxiety episodes and raw sublingual for daily maintenance. Reports reduced panic attacks without failing workplace drug tests (uses raw form exclusively).
The Competitive Landscape: Why OilWell in Central Asia
You have options. Local bazaars sell “cannabis oil” of unknown origin. Russian and Chinese websites offer cheap products. Here’s the reality:
Traditional RSO (illegal in Central Asia):
- Unknown potency, no testing
- Naphtha/isopropyl solvent residues
- 600-900mg delta-9 THC daily (dangerous doses)
- No terpenes
- Illegal to possess, illegal to transport
- No quality control
Typical Central Asian CBD products:
- Single cannabinoid only (CBD)
- Weak potency (100-500mg total)
- No THCa option
- Often fake or mislabeled
- No COAs
- No psychoactive option when needed
OilWell RSO:
- 16,590mg total cannabinoids across seven compounds
- Lab-tested with full COAs
- Solvent-free production
- Patient-controlled potency (raw → full activation)
- Legal under Farm Bill
- Ships directly to Central Asia
- Complete formula transparency
Pricing and Access for Central Asian Economies
We understand Central Asian economic realities. $129.99 is significant.
Our commitment:
- Open-source formula: If you can’t afford it, make it. We provide the recipe.
- International shipping: Direct access without middlemen markups.
- Bulk discounts: Contact us for family/collective orders.
- Payment flexibility: We accept cryptocurrency for those without international credit cards.
Comparison: A month of pharmaceutical painkillers in Kazakhstan can cost $100-200 and destroys your liver. Our product lasts 1-2 months and provides multi-symptom relief.
Cultural Considerations: Cannabis in Central Asian Context
Historical Context
Cannabis (Cannabis sativa L.) is not foreign to Central Asia. The plant originated in this region. Archaeological evidence shows cannabis use in burial sites across the Pamir Mountains dating back 2,500 years. Soviet-era prohibition criminalized it, but traditional knowledge persisted in remote areas. We’re not introducing something new — we’re reintroducing it with modern science and safety.
Religious and Social Sensitivities
We respect that Central Asian societies are predominantly Muslim, with varying degrees of conservative attitudes toward intoxicants. Our raw THCa option provides therapeutic benefits without psychoactivity — addressing religious concerns about intoxication. We frame our products as wellness tools, not recreational substances.
We also acknowledge the Soviet-era stigma around drug use. Our educational approach emphasizes medical necessity, evidence, and responsible use — not “getting high.”
Gender Considerations
Women in Central Asia often face greater stigma around health issues. Our discreet sublingual format allows female customers to manage conditions (menstrual pain, anxiety, menopause symptoms) privately. We have female customers across the region who report this privacy is essential.
Call to Action: Your Path Forward
If you’re in Central Asia and considering RSO, here’s your honest roadmap:
- Read this entire guide. Understand what the evidence actually says.
- Consult your doctor. If they’re unfamiliar with cannabinoids, share our GENERAL KNOWLEDGE section [1]-[29].
- Start with raw THCa. Use the non-psychoactive option to assess tolerance and benefits.
- Track your response. Keep a journal of symptoms, dose, effects.
- Join the community. Connect with other Central Asian patients using cannabinoids (we can facilitate introductions).
- Consider your legal risk. Understand your country’s specific regulations. We provide documentation, but you accept customs responsibility.
- Order with confidence. Our shipping is discreet, tracked, and guaranteed.
Final Word: Why We’re Here
OilWell Cannabis exists because Bentley got up and walked. Because Colin quit benzos and rebuilt his life. Because we believe Central Asian patients deserve the same access to evidence-based cannabinoid medicine as patients in Houston or Amsterdam.
We’re not here to sell you hope. We’re here to give you information, a quality product, and the freedom to choose. The Silk Road carried cannabis for millennia. We’re just making sure the modern version is safe, legal, and effective.
Order today: OilWellCBD.com
Questions for Central Asian customers: [email protected]
Phone (WhatsApp available): +1 (832) 416-2816
We ship to Almaty, Astana, Shymkent, Karaganda, Aktobe, Taraz, Pavlodar, Ust-Kamenogorsk, Uralsk, Tashkent, Samarkand, Namangan, Andijan, Bukhara, Nukus, Qarshi, Kokand, Fergana, Margilan, Bishkek, Osh, Jalal-Abad, Karakol, Tokmok, Dushanbe, Khujand, Kulob, Qurghonteppa, Istaravshan, Konibodom, Ashgabat, Türkmenabat, Daşoguz, Mary, Balkanabat, Bayramaly — and every village, town, and city between.
Your health is your right. Your medicine should be your choice. We’re here to make that possible.
THCa Rick Simpson Oil
Full-Spectrum • In-House Extraction
THE OILWELL PASSION PROJECT: THCa RSO
Experience true full-spectrum relief. Our Rick Simpson Oil is meticulously crafted in-house to preserve the complete cannabinoid and terpene profile of the plant. Potent, pure, and profound.
- 🌿 Maximum Potency
- 🔬 Third-Party Lab Tested
- 🚀 Same-Day Delivery Available